Table 3.
mouse strain | development/ phenotype |
apoptotic/ non-apoptotic/unspecified effect | reference | |
---|---|---|---|---|
Casp-2 −/− | C57BL/6J | normal development |
decreased number of oocytes, increased number of motoneurons |
[46] |
Casp-2 −/− | 129/sv×C57BL/6 | normal development | normal apoptosis of thymocytes induced by various stimuli, normal apoptosis of neurons in absence of NGF | [70] |
Casp-2 −/− | C57BL/6J | reduced sensitivity to heat-shock | reduced cell death | [296] |
Casp-2 −/− | C57Bl/6 | premature ageing | compromised ability to clear oxidatively damaged cells | [67] |
Casp-2 −/− /MMTV | 129/B6 | increased tumor acquisition | cell cycle defects, genomic instability | [75] |
Casp-2 −/− | C57BL/6J | premature ageing | increased oxidative stress | [15] |
Casp-2 −/− | C57BL/6J | age-related bone loss | increased number of osteoclasts due to reduced apoptosis and increased differentiation | [71, 72] |
Casp-2 −/− | C57BL/6J | reduced white adipose mass, smaller white adipocytes etc. | altered balance in fuel choice towards increased carbohydrate utilisation due to mild energy stress | [76] |
Casp-8 −/− | C57BL/6 | abnormalities of heart etc.-prenatally lethal | abnormal receptor-dependent pathway of apoptosis | [68] |
Casp-8 −/− (conditional T-cells-specific) |
C57BL/6 | inability of immune response to viral infection | resistance of T-cells to death mediated by anti-CD95 antibody | [90] |
Casp-8−/−(conditional-several types) | MF-1 | lethal/ non-lethal phenotypes | apoptotic/non-apoptotic engagement in dependence of the targeted cells | [97] |
Casp-8 −/− (conditional B cells-specific) |
- | altered responses of B cells to different stimuli |
B cells: abrogation of Fas-mediated apoptosis, failure of induced proliferation, altered ab production |
[91] |
Casp-8 −/− (conditional B cells-specific) |
129/J × C57BL/6 | normal cell subpopulations in bone marrow | resistance to DR mediated apoptosis, defective B cells expansion response to TLR4 stimulation, attenuated antibody production upon viral infection | [105] |
Casp-8 −/− (conditional keratinocytes-specific) |
C57BL/6 | inflammatory diseases of the skin-lethal by postnatal day 7 |
constitutive phosphorylation of interferon regulatory factor (irf) 3 and tank-binding |
[94] |
Casp-8 −/− (conditional epidermis-specific) |
- | epidermal hyperplasia | increased stem cell proliferation and cutaneous inflammation regulated by il-1α | [102] |
Casp-8 −/− (conditional hepatocytes-specific) |
- | abnormal hepatocyte reaction to damage | apoptotic and non-apoptotic mechanisms of response to different stimuli | [106, 107] |
Casp-8 −/− (conditional macrophage-specific) |
C57BL/6 | mild systemic inflammatory disease | unchecked ripk3 activity | [101] |
Casp-8-/- (conditional endothelium -specific) |
- | reduced retina angiogenesis | reduced endothelial proliferation, sprouting, and migration, destabilization cadherin | [32] |
Casp-8−/−D387A* | C57BL/6 | normal development | reduced Fas-induced apoptosis of T cells, preservation of fas-mediated non-apoptotic signalling | [97] |
Casp-9 −/− |
129/C57BL/6 129/CD1 |
severe brain defect-prenatally lethal | resistance of different cells to apoptotic stimuli | [124] |
Casp-9 −/− | C57BL/6 |
severe brain malformation- prenatally lethal |
reduced apoptosis and activation of caspase-3 in brain, resistance of T cells to different apoptotic stimuli | [69] |
Casp-9 −/− | C57BL/6 | defects and size reduction of the inner ear | decrease of Apaf-1 dependent apoptosis | [116] |
Casp-9 −/− | C57BL/6 | misrouted axons | abnormal cleavage of sema7a | [122] |
Casp-9 −/− | C57BL/6 | increased number of oocytes | decreased apoptotic elimination of oocytes during a narrow window between 18.5 and 21.5 d.p.c. | [125] |
Casp-9 −/− (conditional HFSC-specific) |
- | accelerated wound repair | induction of apoptotic-engaged state, serving as mitogenic signalling centres by releasing wnt3 | [129] |